American College of Endocrinology position statement on the insulin resistance syndrome.

By D. Einhorn, G. Reaven, R. Cobin, E. Ford, O. Ganda, Y. Handelsman, Richard Hellman, P. Jellinger, D. Kendall, Ronald M. Krauss and 6 more. Endocrine Practice, 2003

1,104 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Genetics

View Paper: https://www.semanticscholar.org/paper/a62cb63fa6d054baf88a4de21ec4137b64fad431

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. S. Grundy
2. Jaspinder Kaur
3. I. Azevedo
4. R. Monteiro
5. E. Ford
6. Lorraine O'Driscoll
7. Sadhbh O’Neill

In Genetics

1. S. Grundy
2. Jaspinder Kaur
3. E. Ford

Citations in the corpus

• A Comprehensive Review on Metabolic Syndrome (2014, methodology): “On the other hand, the short-term (5–10 years) risk is better calculated using the classical algorithms (Framingham,REGICOR {RegistreGIronı́ del COR}), as they include age, sex, total cholesterol or LDL, and smoking [4].”
• Metabolic syndrome: definitions and controversies (2011, neutral): “(2003) [142]”
• Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. (2005, background): “Subsequently, the American Association of Clinical Endocrinologists offered its views regarding the definition of the metabolic syndrome (4).”
• Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. (2004, background): “This latter conference considered the following issues: (1) pathogenesis and presentation of the metabolic syndrome, (2) management of underlying risk factors, (3) management of metabolic risk factors, and (4) unresolved issues and research challenges.”